INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 8,011 Value ($000) $669 Avg Close — Range —
Q3 2024
Shares 14,434 Value ($000) $1,056 Avg Close — Range —
Q2 2024
Shares 23,618 Value ($000) $1,618 Avg Close — Range —
Q1 2024
Shares 4,868 Value ($000) $337 Avg Close — Range —
Q4 2023
Shares 3,039 Value ($000) $218 Avg Close — Range —